BioMarin Pharmaceuticals BMRN Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's change in other assets?
- BioMarin Pharmaceuticals (BMRN) reported change in other assets of -$1.48M in Q1 2026.
- How has BioMarin Pharmaceuticals's change in other assets changed year-over-year?
- BioMarin Pharmaceuticals's change in other assets decreased by 191.4% year-over-year, from $1.62M to -$1.48M.
- What is the long-term trend for BioMarin Pharmaceuticals's change in other assets?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's change in other assets has grown at a 55.5% compound annual growth rate (CAGR), from $6.59M to $38.57M.
- What does change in other assets mean?
- The change in miscellaneous long-term assets.
- How do you interpret change in other assets?
- Significant changes often reflect non-recurring accounting adjustments or strategic long-term investments.
- How does change in other assets compare across companies?
- Varies significantly based on company-specific accounting policies and long-term asset structures.